NKG2D+CD4+ T cell subset segregation in juvenile-onset SLE and controls
| NKG2D+CD4+ T cells | Active disease | Inactive disease | Controls |
| n = 13 | n = 14 | n = 14 | |
| Naïve (CD45RO−CCR7+) | 5.3% (±2.8)a | 6.1% (±4) | 73.5% (±9) |
| Central memory (CD45RO−CCR7+) | 45.8% (±13.4) | 47.1% (±14.3) | 17.9% (±8.1) |
| Effector memory (CD45RO+CCR7−) | 46.9% (±14.2) | 48.9% (±13.7) | 8.7% (±5.6) |
| NKG2D+CD4+ T cells | Active disease | Inactive disease | Controls |
| n = 13 | n = 14 | n = 14 | |
| Naïve (CD45RO−CCR7+) | 5.3% (±2.8)a | 6.1% (±4) | 73.5% (±9) |
| Central memory (CD45RO−CCR7+) | 45.8% (±13.4) | 47.1% (±14.3) | 17.9% (±8.1) |
| Effector memory (CD45RO+CCR7−) | 46.9% (±14.2) | 48.9% (±13.7) | 8.7% (±5.6) |
Mean (in percent) ± SD of NKG2D+CD4+ T cells positive for the indicated phenotype by flow cytometry.